Resisting the Urge to Smoke and Craving during a Smoking Quit Attempt on Varenicline: Results from a Pilot FMRI Study

References

• Fiore, M. C., C. R. Jaen, T.I. Baker, W.C. Bailey, N.L. Benowitz, S. J. Curry, SF Dorfman, ES Froelicher, M.G. Goldstein, CG Healton, PN Henderson, RB Heyman, HK Koh, TE Kottke, HA Lando, RE Mecklenburg, RJ Mermelstein, P.D. Mullen, C. T. Orleans, L. Robinson, M. L. Stitzer, AC Tommasello, L Villejo, and M. E. Wewers Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: Public Health Services, 2008.
   Google Scholar
• Garrison GD, Dugan SE. Varenicline: A first-line treatment option for smoking cessation. Clin Ther 2009; 31:463–491.
   PubMed Web of Science ®Google Scholar
• Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation. Trends Pharmacol Sci 2007; 28:316–325.
   PubMed Web of Science ®Google Scholar
• West R, Baker CL, Cappelleri JC, Bushmakin AG. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology 2008; 197:371–377.
   PubMed Web of Science ®Google Scholar
• Killen JD, Fortmann SP. Craving is associated with smoking relapse: Findings from three prospective studies. Exp Clin Psychopharmacol 1997; 5:137–142.
   PubMed Web of Science ®Google Scholar
• Shiffman S, Gnys M, Richards TJ, Paty JA, Hickcox M, Kassel JD. Temptations to smoke after quitting: A comparison of lapsers and maintainers. Health Psychol 1996; 15:455–461.
   PubMed Web of Science ®Google Scholar
• Carter BL, Tiffany ST. Meta-analysis of cue-reactivity in addiction research. Addiction 1999; 94:327–340.
   PubMed Web of Science ®Google Scholar
• Warthen MW, Tiffany ST. Evaluation of cue reactivity in the natural environment of smokers using ecological momentary assessment. Exp Clin Psychopharmacol 2009; 17:70–77.
   PubMed Web of Science ®Google Scholar
• Brody AL, Mandelkern MA, Olmstead RE, Jou J, Tiongson E, Allen V, Scheibal D, London ED, Monterosso JR, Tiffany ST, Korb A, Gan JJ, Cohen MS. Neural substrates of resisting craving during cigarette cue exposure. Biol Psychiatry 2007; 62:642–651.
   PubMed Web of Science ®Google Scholar
• Smolka MN, Buhler M, Klein S, Zimmermann U, Mann K, Heinz A, Braus DF. Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology 2006; 184:577–588.
   PubMed Web of Science ®Google Scholar
• Due DL, Huettel SA, Hall WG, Rubin DC. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging. Am J Psychiatry 2002; 159:954–960.
   PubMed Web of Science ®Google Scholar
• Hartwell, KJ, KA Johnson, Li Xingbao, H Myrick, T LeMatty, MS George, and KT Brady. Neural correlates of craving and resisting craving for tobacco in nicotine dependent smokers. Addict Biol 2011; 16:654–666.
   PubMed Web of Science ®Google Scholar
• Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat 2009; 36:235–243.
   PubMed Web of Science ®Google Scholar
• Tiffany ST, Cox LS, Elash CA. Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers. J Consult Clin Psychol 2000; 68: 233–240.
   PubMed Web of Science ®Google Scholar
• Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, Goldman M, Detre JA, O’Brien CP, Childress AR. Effects of varenicline on smoking cue-triggered neural and craving responses. Arch Gen Psychiatry 2011; 68:516–526.
   PubMed Web of Science ®Google Scholar
• Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978; 3:235–241.
   PubMed Web of Science ®Google Scholar
• Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 2001; 3:7–16.
   PubMedGoogle Scholar
• Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav 2007; 32:912–923.
   PubMed Web of Science ®Google Scholar
• Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. NeuroImage 2002; 17:825–841.
   PubMed Web of Science ®Google Scholar
• Beckmann CF, Jenkinson M, Smith SM. General multilevel linear modeling for group analysis in FMRI. NeuroImage 2003; 20:1052–1063.
   PubMed Web of Science ®Google Scholar
• Woolrich MW, Ripley BD, Brady M, Smith SM. Temporal autocorrelation in univariate linear modeling of FMRI data. NeuroImage 2001; 14:1370–1386.
   PubMed Web of Science ®Google Scholar
• Fu, S. S., D. J. Burgess, D. K. Hatsukami, S. Noorbaloochi, B. A. Clothier, S. Nugent, and M. van Ryn. Race and nicotine replacement treatment outcomes among low-income smokers. Am J Prev Med 2008; 35:S442–S448.
   Google Scholar
• Piper, M. E., J. W. Cook, T. R. Schlam, D. E. Jorenby, S. S. Smith, D. M. Bolt, and W. Y. Loh. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res 2010; 12:647–657.
   PubMed Web of Science ®Google Scholar
• Covey, L. S., M. Botello-Harbaum, A. H. Glassman, J. Masmela, C. LoDuca, V. Salzman, and J. Fried. Smokers’ response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. Ethn Dis 2008; 18:59–64.
   PubMed Web of Science ®Google Scholar
• Malin DH. Nicotine dependence: Studies with a laboratory model. Pharmacol Biochem Behav 2001; 70:551–559.
   PubMed Web of Science ®Google Scholar
• Coe, JW, PR Brooks, MG Vetelino, MC Wirtz, EP Arnold, J Huang, SB Sands, TI Davis, LA Lebel, CB Fox, A Shrikhande, JH Heym, E Schaeffer, H Rollema, Y Lu, RS Mansbach, LK Chambers, CC Rovetti, DW Schulz, FD 3rd Tingley, and BT O’Neill. Varenicline: An alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem 2005; 48: 3474–3477.
   PubMed Web of Science ®Google Scholar
• McKee SA, Weinberger AH, Shi J, Tetrault J, Developing CS. Validating a human laboratory model to screen medications for smoking cessation. Nicotine Tob Res 2012; Volume 14, Issue 11 pp. 1362–1371.
   Google Scholar
• McClernon, F., Rachel Kozink, Avery Lutz, and Jed Rose. Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. Neuropsychopharmacol 2005; 30:1940–1947.
   PubMed Web of Science ®Google Scholar
• McClernon F, Kozink R, Lutz A, Rose J. 24-h smoking abstinence potentiates fMRI-BOLD activation to smoking cues in cerebral cortex and dorsal striatum. Psychopharmacol 2009; 204:25–35.
   PubMed Web of Science ®Google Scholar
• Rose JE, McClernon FJ, Froeliger B, Behm FM, Preud’homme X, Krystal AD. Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. Biol Psychiatry 2011; 70:794–799.
   PubMed Web of Science ®Google Scholar
• Myers CS, Taylor RC, Moolchan ET, Heishman SJ. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacol 2008; 33:588–598.
   PubMed Web of Science ®Google Scholar
• Patterson, F., C. Jepson, A. A. Strasser, J. Loughead, K. A. Perkins, R. C. Gur, J. M. Frey, S. Siegel, and C. Lerman. Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry 2009; 65:144–149.
   PubMed Web of Science ®Google Scholar
• Thomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD. Cognitive improvement by activation of α7 nicotinic acetylcholine receptors: From animal models to human pathophysiology. Curr Pharm Des 2010; 16:323–343.
   PubMed Web of Science ®Google Scholar